This new MYC-LINC02167 axis not only enhances our understanding of MYC’s role in cancer metastasis but also provides an alternative approach for MYC-targeted therapy by indirectly reducing MYC’s oncogenic effects through LINC02167 inhibition. This evidence concerns the gene MYC and cancer.